TI
RCKT icon

Trexquant Investment’s Rocket Pharmaceuticals RCKT Stock Holding History

Trexquant Investment’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,613
Closed -$251K – 1814
2025
Q1 		$251K Buy
+37,613
New +$372K ﹤0.01% 1427
2021
Q2 		– Sell
-5,681
Closed -$252K – 1432
2021
Q1 		$252K Sell
5,681
-12,642
-69% -$694K 0.02% 845
2020
Q4 		$1M Buy
+18,323
New +$668K 0.11% 257
2019
Q1 		– Sell
-14,602
Closed -$216K – 1255
2018
Q4 		$216K Buy
+14,602
New +$242K 0.01% 889
2017
Q1 		– Sell
-5,931
Closed -$145K – 1283
2016
Q4 		$145K Buy
+5,931
New +$169K 0.02% 875

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Trexquant Investment's RCKT Position: Q2 2025 in Review

Trexquant Investment sold out of Rocket Pharmaceuticals (RCKT) in Q2 2025, closing a stake of 37,613 shares — an estimated $251K sold.

Trexquant Investment first reported a position in RCKT in Q4 2016 and held it in 5 quarters. The position peaked at $1M in Q4 2020. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • Trexquant Investment reported no remaining Rocket Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Trexquant Investment sold 37,613 Rocket Pharmaceuticals shares in Q2 2025, an estimated $251K.
  • Trexquant Investment first reported a position in Rocket Pharmaceuticals in Q4 2016 and held it in 5 quarters.
  • Trexquant Investment's Rocket Pharmaceuticals position peaked at $1M in Q4 2020.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.